16th annual Pain Therapeutics
Date: | 23-May-16 to 24-May-16 |
Location: | Holiday Inn Kensington Forum / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
SMi’s 16th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.
Aimed at an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2016 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency.
Understanding drug development mechanisms, neuropathic pain, severe chronic pain, sodium channels and industry challenges will be a major focus, as will hearing from a selection of leading pharmaceutical companies currently developing novel analgesic treatments. This will include presentations from Glenmark, Pfizer, GSK, Grunenthal, Nektar Pharmaceuticals and Novartis.
Interactive panel discussions on experimental clinical trials and alternative approaches to pain therapy will be just some of the highlights at the 16th annual show when it returns to London this spring.
Unrivalled Speaker Line-up Includes:
• Steven Kamerling, Therapeutic Area Head for Pain & Inflammation, Zoetis
• Stephen Doberstein, Senior Vice President and Chief Scientific Officer, Nektar Pharmaceuticals
• Shaloo Pandhi, Global Program Medical Director, Novartis
• Neelima Khairatkar Joshi, Sr Vice President, Glenmark Pharmaceuticals
• Richard Butt, Senior Director, Research Project Leader, Clinical Research, Pfizer
• Ozgur Sancak, Global Medical Science Lead – Pain, RB
• Thomas Christoph, Senior Director, Head of Pain Pharmacology, Grunenthal
• Chao Chen, Therapy Area Head, GSK
• Catherine Stehman-Breen, VP Clinical Sciences, Regeneron
A detailed agenda and further information is available online at http://www.pain-therapeutics.co.uk
Visit the website for earlybird rates and to download a brochure.
Aimed at an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2016 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency.
Understanding drug development mechanisms, neuropathic pain, severe chronic pain, sodium channels and industry challenges will be a major focus, as will hearing from a selection of leading pharmaceutical companies currently developing novel analgesic treatments. This will include presentations from Glenmark, Pfizer, GSK, Grunenthal, Nektar Pharmaceuticals and Novartis.
Interactive panel discussions on experimental clinical trials and alternative approaches to pain therapy will be just some of the highlights at the 16th annual show when it returns to London this spring.
Unrivalled Speaker Line-up Includes:
• Steven Kamerling, Therapeutic Area Head for Pain & Inflammation, Zoetis
• Stephen Doberstein, Senior Vice President and Chief Scientific Officer, Nektar Pharmaceuticals
• Shaloo Pandhi, Global Program Medical Director, Novartis
• Neelima Khairatkar Joshi, Sr Vice President, Glenmark Pharmaceuticals
• Richard Butt, Senior Director, Research Project Leader, Clinical Research, Pfizer
• Ozgur Sancak, Global Medical Science Lead – Pain, RB
• Thomas Christoph, Senior Director, Head of Pain Pharmacology, Grunenthal
• Chao Chen, Therapy Area Head, GSK
• Catherine Stehman-Breen, VP Clinical Sciences, Regeneron
A detailed agenda and further information is available online at http://www.pain-therapeutics.co.uk
Visit the website for earlybird rates and to download a brochure.
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today